JMDC (4483.T) Azione Prezzo
JMDC Prezzo
Negli ultimi 8 anni JMDC ha aumentato il fatturato del 42,1% all'anno, raggiungendo 49,82 miliardi JPY. L'utile per azione è cresciuto del 37,1% all'anno negli ultimi 8 anni. Per JMDC, il margine netto del 13,6% risulta in calo rispetto al 14,9% di alcuni anni fa. Al prezzo attuale il rendimento da dividendo è pari a circa il 0,93%. Il payout ratio è pari a circa il 21% degli utili. Il dividendo è cresciuto del 35,8% all'anno negli ultimi 4 anni. Il target di prezzo di consenso a 12 mesi per JMDC è 5508,00 JPY, circa il 50,5% sopra il prezzo attuale di mercato. Su 18 analisti, 17 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
JMDC Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
JMDC Azione e analisi azionaria
Domande frequenti sull'azione JMDC
JMDC Inc is a leading company with a unique business model. They specialize in offering comprehensive health data analysis and consulting services. Their innovative solutions enable healthcare professionals to make informed decisions and improve patient outcomes. By leveraging cutting-edge technology and partnering with industry experts, JMDC Inc is able to provide valuable insights and support to healthcare organizations. With a strong focus on data-driven solutions and continuous innovation, JMDC Inc strives to drive positive changes in the healthcare sector. Overall, JMDC Inc's business model revolves around delivering impactful healthcare data analysis and consulting services to empower the industry.
JMDC Inc is primarily active in the healthcare and data analysis industries.
The main competitors of JMDC Inc in the market are [insert names of competitors]. These companies operate in the same industry as JMDC Inc and offer similar products and services. As a professional stock website, we provide comprehensive information on JMDC Inc's competitors, financial performance, and market analysis. Stay informed about the competitive landscape and make well-informed investment decisions.
JMDC Inc is a leading company in the healthcare industry. It was founded in Japan in [year] and has since established a strong reputation for its data analysis and consulting services. With a focus on healthcare-related information, JMDC Inc offers valuable insights to various stakeholders within the industry, including medical institutions and pharmaceutical companies. The company has a rich history of delivering innovative solutions to improve healthcare outcomes and optimize operational efficiency. JMDC Inc's commitment to excellence and its continual growth make it a trusted partner in the healthcare sector.
Some significant milestones achieved by JMDC Inc include expanding its market presence, achieving consistent revenue growth, and introducing innovative healthcare solutions. JMDC Inc has successfully forged strategic partnerships with prominent healthcare providers, resulting in increased market share and improved accessibility to its services. With a strong commitment to delivering high-quality data analytics and software solutions, JMDC Inc has consistently witnessed revenue growth year after year. Furthermore, the company has been at the forefront of developing cutting-edge healthcare technologies, optimizing patient care, and enhancing overall healthcare efficiency. JMDC Inc continues to strive for excellence by embracing innovative solutions and expanding its reach in the healthcare industry.
JMDC Inc is primarily present in Japan.
JMDC Inc represents strong values and a clear corporate philosophy. With a focus on providing comprehensive healthcare information services, JMDC Inc aims to contribute to the improvement of medical care in Japan. The company is committed to promoting transparency, accessibility, and efficiency in the healthcare industry through their innovative solutions. By leveraging advanced technology and data analysis, JMDC Inc strives to enhance medical decision-making processes and drive positive patient outcomes. Their dedication to integrity, professionalism, and continuous growth underpin their commitment to delivering high-quality healthcare solutions. JMDC Inc's values and corporate philosophy are deeply rooted in their mission to create a healthier and more sustainable society.
Gli analisti fissano attualmente un prezzo obiettivo medio di 5503,75 JPY per l’azione JMDC (mediana: 5508,00 JPY), pari a +50,4 % rispetto all’ultimo prezzo. Il consenso si basa su 18 giudizi di analisti.
18 analisti valutano attualmente l’azione JMDC: 17 raccomandano l’acquisto, 1 la tenuta e 0 la vendita.
Convertita al tasso di cambio attuale, l’azione JMDC quota 20,79 EUR (3660,00 JPY).
L’azione JMDC (4483.T) è quotata su 3 borse, tra cui: Tokio (JPX) (4483.T), Frankfurt (6JM.F), München (6JM.MU).
JMDC Inc is a Japanese company that specializes in providing medical services and products. The company was founded in 1987 and has since expanded its business into various areas. Its main business fields include data analysis, health management, and medical products. JMDC Inc collects medical data and uses it to gain insights into diseases and treatment options. These insights are then used to develop new medical products and improve existing ones. The company also offers solutions for corporate health promotion, such as disease prevention programs, support for lifestyle changes, and promoting a healthy work environment. In addition, JMDC Inc offers a variety of medical products, including blood pressure measurement devices, diabetes monitoring devices, and allergy detection devices. Another product is the "Smart Seat," a sensor system that aims to improve people's sitting position and reduce back pain. A key part of JMDC Inc's business model is its joint venture with Aetna Japan, a leading provider of health insurance in Japan. This partnership allows JMDC Inc to expand its capabilities in health management and develop new products and services in close collaboration with Aetna Japan. Overall, JMDC Inc's business model focuses on gaining insights into diseases through data analysis and health management, and incorporating these insights into the development of new medical products and services. The company strives to play a leading role in promoting health and well-being in Japan and beyond.
Il fatturato di JMDC ammonta a 49,82 miliardi JPY. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il profitto di JMDC ammonta a 6,77 miliardi JPY. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di JMDC è attualmente 35,70. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione JMDC.
Il rapporto prezzo/fatturato (P/S) di JMDC è attualmente 4,85. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione JMDC.
Il Quality Score AlleAktien per JMDC è 5/10.
L'ISIN di JMDC è JP3386690006. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di JMDC è A2PWQC. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di JMDC è 4483.T. Con questo simbolo di borsa vengono negoziate le azioni JMDC in borsa.
Azione JMDC
Gruppo di pari di JMDC
JMDC Ticker
JMDC FIGI
Altre metriche e analisi di JMDC in Deep Dive.
La nostra analisi azionaria dell'azione JMDC include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di JMDC. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: